ScholarLens Back to search
2012•Advances in Cardiovascular DiseasesRequires access

Advances in Using Ivabradine in Cardiovascular Disease

Lanfeng Wang

Open publisher page 0 citations

Abstract

Ivabradine is the first cardiac pacing current(If current) inhibitor that specifically reduces heart rate.To date,there have been numerous ivabradine-related animal experiments and large clinical trials.This article reviews advances in using ivabradine in cardiovascular disease.

About this research paper

What this paper is about

Ivabradine is the first cardiac pacing current(If current) inhibitor that specifically reduces heart rate.To date,there have been numerous ivabradine-related animal experiments and large clinical trials.This article reviews advances in using ivabradine in cardiovascular disease.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ivabradine is the first cardiac pacing current(If current) inhibitor that specifically reduces heart rate.To date,there have been numerous ivabradine-related animal experiments and large clinical trials.This article reviews advances in using ivabradine in cardiovascular disease.

Key concepts: Ivabradine, Medicine, Cardiology, Internal medicine, Disease, Clinical trial, Heart rate, Blood pressure

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Advances in Using Ivabradine in Cardiovascular Disease — Research Paper | ScholarLens